Prologue Medicines
MA - BostonBiotechnology
Focus: Prologue Medicines is a Boston-based biotech company specializing in viral-derived biologics with a pipeline spanning infectious diseases, neurology, gastroenterology, oncology, and ophthalmology. As a publicly traded mid-cap biotech with 51-200 employees, the company operates at the intersection of virology and therapeutic innovation.
Profile data last refreshed 41m ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
82+26 this month
Hot — 71 jobs added in 30d
Net +26 (71 new, 45 removed). Aggressive expansion phase.
Should You Work at Prologue Medicines?
AI assessmentBest suited for early-career scientists and computational biologists seeking deep technical work in a specialized modality, but with elevated visibility risk due to lack of clinical-stage programs.
Why Work Here
- Heavy R&D focus with 26 active positions in Research & Development signals meaningful scientific work and technical depth in a specialized modality (viral-derived biologics)
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Prologue Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.